Cca 2013 version 10 step therapy criteria

Step Therapy Criteria
Commonwealth Care Alliance 2013
Last Updated: 03/2013
Effective: April 1, 2013
CCA ANTIDEPRESSANT (SNRI) ST 2013C
Products Affected
Criteria
Patient needs to have paid claims for one of the following Step 1 drugs with a day supply of at least 30 days prior to filling a Step 2 drug. Step 1 drugs: citalopram, citalopram Hbr, escitalopram, fluoxetine Dr, fluoxetine Hcl, fluvoxamine maleate, paroxetine Hcl, Rapiflux, sertraline Hcl, venlafaxine Hcl, venlafaxine Hcl Er. Step 2 Drugs: Cymbalta, Pristiq, Savella. Patients who have taken a step 2 drug at any time in the past may restart. Authorization may be given for a step 2 drug if the patient is currently taking the requested agent. Patients aged 18 years of less: approve Cymbalta or Pristiq without a trial of a step 1 agent. Symptoms of suicidal ideation: approve Cymbalta or Pristiq without a trial of a step 1 agent. Stress urinary incontinence: approve Cymbalta without a trial of a step 1 agent. Fibromyalgia: approve Cymbalta or Savella without a trial of a step 1 agent. Chronic musculoskeletal pain (eg, low back pain or pain due to osteoarthritis): approve Cymbalta without a trial of a step 1 agent. Chronic musculoskeletal pain (eg, low back pain or pain due to osteoarthritis) and Diabetic peripheral neuropathy: approve Cymbalta CCA BISPHOSPHONATES 2013S
Products Affected
Criteria
Patient needs to have a paid claim for one of the following Step 1 drugs prior to filling a Step 2 drug. Step 1 drugs: alendronate, ibandronate. Step CCA NASAL CORTICOSTERIODS ST 2013S
Products Affected
Criteria
Patient needs to have a paid claim for one of the following Step 1 drugs prior to filling a Step 2 drug. Step 1 drugs: flunisolide, fluticasone propionate, Nasonex, Rhinocort Aqua, Veramyst, triamcinolone. Step 2 CCA SEDATIVE HYPNOTICS ST 2013S
Products Affected
Criteria
Patient needs to have a paid claim for one of the following Step 1 drugs prior to filling a Step 2 drug. Step 1 drugs: generic zolpidem (including zolpidem CR) or zaleplon. Step 2 drugs: Rozerem, Edluar, Zolpimist. CCA SSRI ANTIDEPRESSANTS (SSRI) ST 2013S
Products Affected
Criteria
Patient needs to have paid claims for one of the following Step 1 drugs (must be generic) with a day supply of at least 30 days prior to filling a Step 2 drug. Step 1 drugs: citalopram hydrobromide, escitalopram, fluoxetine HCL, fluvoxamine maleate, paroxetine HCL, paroxetine ER, sertraline HCL.Step 2: Luvox CR, Viibryd. A
O
P
B
S
C
Cca Bisphosphonates 2013s . 2 Cca Nasal Corticosteriods St 2013s . 3 V
Cca Ssri Antidepressants (ssri) St 2013s . 5 Cymbalta . 1 Z
L

Source: http://commonwe.itg.net/downloads/Step_Therapy_Criteria_Apr2013.pdf

Cmbx12

4.3.1 Estimating the Width of a Room RevisedThe unconditional analysis of the room width estimated by two groups ofstudents in Chapter˜3 led to the conclusion that the estimates in metres areslightly larger than the estimates in feet. Here, we reanalyse these data in aconditional framework. First, we convert metres into feet and store the vectorof observations in a variable y:R> data("ro

bananarepublican.info

Copyright ©2001 American Academy of Orthopaedic Surgeons What guidelines/algorithms (both operative and nonoperative)are there for the treatment of osteolysis?Osteolysis is the conclusion of a complex particle-induced biologic processresulting in bone loss and in some cases implant loosening.1-5 Early diagnosisof osteolysis requires interval radiographic evaluation of patients with jointreplac

Copyright © 2018 Medical Abstracts